| Product Code: ETC9506919 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import of bone morphogenetic proteins in 2024 continued to be dominated by key suppliers such as the United States, Netherlands, Brazil, United Kingdom, and India. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. Despite a significant negative compound annual growth rate (CAGR) of -26.83% from 2020 to 2024, the growth rate in 2024 saw a sharp decline of -67.36% compared to the previous year. This trend suggests a challenging market environment for bone morphogenetic proteins imports in Suriname, with potential implications for industry stakeholders.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Bone Morphogenetic Proteins Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Bone Morphogenetic Proteins Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Bone Morphogenetic Proteins Market - Industry Life Cycle |
3.4 Suriname Bone Morphogenetic Proteins Market - Porter's Five Forces |
3.5 Suriname Bone Morphogenetic Proteins Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Suriname Bone Morphogenetic Proteins Market Revenues & Volume Share, By Applications, 2021 & 2031F |
4 Suriname Bone Morphogenetic Proteins Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidences of orthopedic and spinal disorders in Suriname |
4.2.2 Growing demand for advanced medical technologies and treatments |
4.2.3 Rising healthcare expenditure and investments in healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost associated with bone morphogenetic proteins |
4.3.2 Limited awareness and access to advanced medical treatments in certain regions of Suriname |
5 Suriname Bone Morphogenetic Proteins Market Trends |
6 Suriname Bone Morphogenetic Proteins Market, By Types |
6.1 Suriname Bone Morphogenetic Proteins Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Suriname Bone Morphogenetic Proteins Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Suriname Bone Morphogenetic Proteins Market Revenues & Volume, By rhBMP-2, 2021- 2031F |
6.1.4 Suriname Bone Morphogenetic Proteins Market Revenues & Volume, By rhbmp-7, 2021- 2031F |
6.2 Suriname Bone Morphogenetic Proteins Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Suriname Bone Morphogenetic Proteins Market Revenues & Volume, By Spinal Fusion, 2021- 2031F |
6.2.3 Suriname Bone Morphogenetic Proteins Market Revenues & Volume, By Trauma, 2021- 2031F |
6.2.4 Suriname Bone Morphogenetic Proteins Market Revenues & Volume, By Reconstructive, 2021- 2031F |
6.2.5 Suriname Bone Morphogenetic Proteins Market Revenues & Volume, By Oral, 2021- 2031F |
7 Suriname Bone Morphogenetic Proteins Market Import-Export Trade Statistics |
7.1 Suriname Bone Morphogenetic Proteins Market Export to Major Countries |
7.2 Suriname Bone Morphogenetic Proteins Market Imports from Major Countries |
8 Suriname Bone Morphogenetic Proteins Market Key Performance Indicators |
8.1 Number of orthopedic and spinal surgeries utilizing bone morphogenetic proteins |
8.2 Adoption rate of bone morphogenetic proteins in orthopedic and spinal procedures |
8.3 Number of healthcare facilities offering bone morphogenetic proteins as a treatment option |
9 Suriname Bone Morphogenetic Proteins Market - Opportunity Assessment |
9.1 Suriname Bone Morphogenetic Proteins Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Suriname Bone Morphogenetic Proteins Market Opportunity Assessment, By Applications, 2021 & 2031F |
10 Suriname Bone Morphogenetic Proteins Market - Competitive Landscape |
10.1 Suriname Bone Morphogenetic Proteins Market Revenue Share, By Companies, 2024 |
10.2 Suriname Bone Morphogenetic Proteins Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |